Meihua International Medical Technologies Co. Ltd. (MHUAF) - Net Assets
Based on the latest financial reports, Meihua International Medical Technologies Co. Ltd. (MHUAF) has net assets worth $188.93 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($207.18 Million) and total liabilities ($18.25 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Meihua International Medical Technologie tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $188.93 Million |
| % of Total Assets | 91.19% |
| Annual Growth Rate | 22.96% |
| 5-Year Change | 75.31% |
| 10-Year Change | N/A |
| Growth Volatility | 12.32 |
Meihua International Medical Technologies Co. Ltd. - Net Assets Trend (2018–2025)
This chart illustrates how Meihua International Medical Technologies Co. Ltd.'s net assets have evolved over time, based on quarterly financial data. See Meihua International Medical Technologie defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Meihua International Medical Technologies Co. Ltd. (2018–2025)
The table below shows the annual net assets of Meihua International Medical Technologies Co. Ltd. from 2018 to 2025. For live valuation and market cap data, see MHUAF market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $188.93 Million | +18.84% |
| 2024-12-31 | $158.98 Million | +8.27% |
| 2023-12-31 | $146.84 Million | +5.88% |
| 2022-12-31 | $138.68 Million | +28.68% |
| 2021-12-31 | $107.77 Million | +27.18% |
| 2020-12-31 | $84.74 Million | +42.04% |
| 2019-12-31 | $59.66 Million | +34.18% |
| 2018-12-31 | $44.46 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Meihua International Medical Technologies Co. Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 199.9% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $111.95 Million | 59.25% |
| Common Stock | $34.89K | 0.02% |
| Other Comprehensive Income | $17.51 Million | 9.27% |
| Other Components | $59.44 Million | 31.46% |
| Total Equity | $188.93 Million | 100.00% |
Meihua International Medical Technologies Co. Ltd. Competitors by Market Cap
The table below lists competitors of Meihua International Medical Technologies Co. Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Lions Bay Capital Inc
V:LBI
|
$7.10 Million |
|
Vivos Therapeutics Inc
NASDAQ:VVOS
|
$7.10 Million |
|
Lupaka Gold Corp.
V:LPK
|
$7.11 Million |
|
Diamond Estates Wines & Spirits Inc
V:DWS
|
$7.11 Million |
|
Advanced Blockchain AG
XETRA:BWQ
|
$7.10 Million |
|
Ajooni Biotech Limited
NSE:AJOONI
|
$7.10 Million |
|
Keyang Electric Machinery Co Ltd
KO:012205
|
$7.09 Million |
|
NYRSTAR
F:3NY1
|
$7.09 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Meihua International Medical Technologies Co. Ltd.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 158,975,547 to 188,931,212, a change of 29,955,665 (18.8%).
- Net income of 6,781,826 contributed positively to equity growth.
- New share issuances of 16,520,000 increased equity.
- Other comprehensive income increased equity by 12,796,493.
- Other factors decreased equity by 6,142,654.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $6.78 Million | +3.59% |
| Share Issuances | $16.52 Million | +8.74% |
| Other Comprehensive Income | $12.80 Million | +6.77% |
| Other Changes | $-6.14 Million | -3.25% |
| Total Change | $- | 18.84% |
Book Value vs Market Value Analysis
This analysis compares Meihua International Medical Technologies Co. Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.02x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | $222.31 | $8.30 | x |
| 2019-12-31 | $247.13 | $8.30 | x |
| 2020-12-31 | $351.02 | $8.30 | x |
| 2021-12-31 | $4.31 | $8.30 | x |
| 2022-12-31 | $589.99 | $8.30 | x |
| 2023-12-31 | $611.24 | $8.30 | x |
| 2024-12-31 | $580.80 | $8.30 | x |
| 2025-12-31 | $502.43 | $8.30 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Meihua International Medical Technologies Co. Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 3.59%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 10.98%
- • Asset Turnover: 0.30x
- • Equity Multiplier: 1.10x
- Recent ROE (3.59%) is below the historical average (15.68%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | 34.81% | 20.44% | 1.21x | 1.40x | $11.03 Million |
| 2019 | 25.87% | 19.38% | 1.09x | 1.23x | $9.47 Million |
| 2020 | 22.48% | 21.38% | 0.84x | 1.25x | $10.57 Million |
| 2021 | 19.44% | 20.14% | 0.76x | 1.27x | $10.17 Million |
| 2022 | 4.52% | 6.04% | 0.63x | 1.18x | $-7.57 Million |
| 2023 | 7.94% | 11.97% | 0.56x | 1.17x | $-3.01 Million |
| 2024 | 6.82% | 11.19% | 0.52x | 1.17x | $-5.05 Million |
| 2025 | 3.59% | 10.98% | 0.30x | 1.10x | $-12.11 Million |
Industry Comparison
This section compares Meihua International Medical Technologies Co. Ltd.'s net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $1,252,702,307
- Average return on equity (ROE) among peers: -94.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Meihua International Medical Technologies Co. Ltd. (MHUAF) | $188.93 Million | 34.81% | 0.10x | $7.10 Million |
| Akoya Biosciences Inc (AKYA) | $7.59 Million | -728.97% | 15.46x | $64.44 Million |
| Align Technology Inc (ALGN) | $-84.67 Million | 0.00% | 0.00x | $12.09 Billion |
| AngioDynamics Inc (ANGO) | $355.71 Million | 3.06% | 0.15x | $447.90 Million |
| AptarGroup Inc (ATR) | $2.71 Billion | 14.48% | 0.94x | $7.66 Billion |
| AtriCure Inc (ATRC) | $483.76 Million | 10.38% | 0.27x | $1.37 Billion |
| Avinger Inc (AVGR) | $-35.69 Million | 0.00% | 0.00x | $1.52 Million |
| Anteris Technologies Global Corp. Common Stock (AVR) | $18.90 Million | -243.53% | 0.62x | $924.75 Million |
| Avantor Inc (AVTR) | $4.86 Billion | 14.14% | 1.77x | $5.44 Billion |
| Azenta Inc (AZTA) | $121.80 Million | -15.11% | 0.16x | $1.05 Billion |
| Baxter International Inc (BAX) | $4.09 Billion | 0.98% | 1.08x | $9.94 Billion |
About Meihua International Medical Technologies Co. Ltd.
Meihua International Medical Technologies Co., Ltd. engages in the research and development, manufacture, and sale of medical devices in the People's Republic of China. The company offers Class I disposable medical devices, including disposable medical X-ray films, medical dry films, dry laser imagers, gauze bandages, examination gloves, pharmaceutical packaging materials and containers, low-dens… Read more